PortfoliosLab logo

Bionano Genomics, Inc. (BNGO)

Equity · Currency in USD · Last updated Mar 26, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Bionano Genomics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,574 for a total return of roughly -84.26%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2023FebruaryMarch
-84.26%
35.99%
BNGO (Bionano Genomics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BNGO

Bionano Genomics, Inc.

Return

Bionano Genomics, Inc. had a return of -24.66% year-to-date (YTD) and -54.17% in the last 12 months. Over the past 10 years, Bionano Genomics, Inc. had an annualized return of -33.91%, while the S&P 500 had an annualized return of 7.13%, indicating that Bionano Genomics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-20.29%-0.66%
Year-To-Date-24.66%3.42%
6 months-42.11%5.67%
1 year-54.17%-10.89%
5 years (annualized)-33.91%7.13%
10 years (annualized)-33.91%7.13%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202323.97%-25.97%
2022-26.21%27.87%-14.10%-27.36%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bionano Genomics, Inc. Sharpe ratio is -0.56. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00NovemberDecember2023FebruaryMarch
-0.56
-0.47
BNGO (Bionano Genomics, Inc.)
Benchmark (^GSPC)

Dividend History


Bionano Genomics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-92.94%
-17.21%
BNGO (Bionano Genomics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bionano Genomics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bionano Genomics, Inc. is 96.85%, recorded on Apr 2, 2020. It took 199 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.85%Sep 28, 2018372Apr 2, 2020199Jan 15, 2021571
-93.06%Feb 17, 2021526Mar 20, 2023
-16.3%Jan 26, 20213Jan 28, 202111Feb 12, 202114
-11.93%Jan 20, 20211Jan 20, 20212Jan 22, 20213
-9.73%Sep 24, 20182Sep 25, 20182Sep 27, 20184

Volatility Chart

Current Bionano Genomics, Inc. volatility is 51.65%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
51.65%
19.50%
BNGO (Bionano Genomics, Inc.)
Benchmark (^GSPC)